Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity-Reference-Cited by-同舟云学术

Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity

Published:2022-08 Issue: Volume:Volume 16 Page:2683-2693
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Dong Zhaoqiang,Wang Yuzhen,Guo Jing,Tian Chuan,Pan Wengu,Wang Hongwei,Yan Jieke

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference47 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline

3. Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

4. National Comprehensive Cancer Network: NCCN clinical prastice guidelines in oncology (NCCN Guidelines®): prostate cancer V.2.2021. National Comprehensive Cancer Network, Inc. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459. Accessed July 29, 2022.

5. TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of formononetin in cancer treatment: An updated review;Biomedicine & Pharmacotherapy;2023-12

2. Hyaluronic Acid-Mediated Phenolic Compound Nanodelivery for Cancer Therapy;Pharmaceutics;2023-06-16

3. Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways;International Journal of Molecular Sciences;2023-06-03

4. Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer;Cancer Chemotherapy and Pharmacology;2023-03-29

5. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy;Frontiers in Pharmacology;2023-02-16